Syncom Formulations Share Price Target 2025 to 2040

Last updated on December 19th, 2024 at 09:20 pm

Syncom Formulations (India) Ltd. is a key player in the pharmaceutical sector, known for its innovative products and cost-effective solutions. With a current share price of ₹20.12, the company holds promise for future growth. Here’s an in-depth analysis of its share price predictions from 2024 to 2040.

About Syncom Formulations

WhatsApp Channel Join Now
Telegram Channel Join Now

Syncom Formulations is an Indian pharmaceutical company specializing in manufacturing and marketing formulations across various therapeutic segments. It serves both domestic and international markets, focusing on affordability and quality.

Company Details

  • Founded: 1988
  • Headquarters: Indore, Madhya Pradesh, India
  • Sector: Pharmaceuticals
  • Products: Tablets, Capsules, Syrups, Ointments
  • Market Reach: India and Exports

Promoter Details

Promoter NameHolding (%)
Institutional Investors12.50
Retail & Others87.50

Syncom Formulations Share Price Target 2024

Growth Factors:

  1. Expanding export markets.
  2. Focus on affordable healthcare products.
  • Minimum Target: ₹22
  • Maximum Target: ₹25

Syncom Formulations Share Price Target 2025

Key Drivers:

  1. Increased investment in R&D for new formulations.
  2. Growth in the domestic healthcare sector.
  • Minimum Target: ₹28
  • Maximum Target: ₹32

Syncom Formulations Share Price Target 2026 to 2030

YearMinimum Target (₹)Maximum Target (₹)
20263540
20274248
20285058
20296072
20307590

Syncom Formulations Share Price Target 2035

Long-Term Catalysts:

  1. Entry into niche therapeutic areas.
  2. Diversification into over-the-counter (OTC) products.
  • Minimum Target: ₹110
  • Maximum Target: ₹135

Syncom Formulations Share Price Target 2040

By 2040, Syncom Formulations is expected to leverage its market presence and innovation to achieve robust growth.

  • Minimum Target: ₹150
  • Maximum Target: ₹180
See also  Kotak Mahindra Bank Share Price Prediction 2024, 2025, 2026 to 2040

Final Thoughts

Syncom Formulations has the potential to grow steadily in the coming years, driven by its focus on affordable medicines and international expansion. However, stock performance depends on market conditions and the company’s execution of its growth plans.

Disclaimer: Stock market investments are subject to risks. Perform thorough research or consult a financial advisor before investing. For more insights, visit moneyphobia.in!

I am skilled Us based content writer with 2+ year Experience I creates engaging, well-researched articles on finance, technology, and industry topics.

Leave a Comment